Medtronic (NYSE: MDT) announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the NC Euphora Noncompliant ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE